ZYVERSA THERAPEUTICS INC (ZVSA)

US98987D3008 - Common Stock

1.25  +0.01 (+0.81%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
9.63M14.42M13.83M7.70M11.83M
Research and Development
1.92M3.21M5.81M2.12M6.47M
Selling, General, and Administrative Expenses
7.71M11.20M8.02M5.57M5.35M
Operating Income
-9.63M-14.42M-13.83M-7.70M-11.83M
Interest Income/Expense
-131.90K500.00-1.03M-593.30K-850.10K
Non Recurring Items
N/A-93.33M0.00213.50K0.00
Income Before Taxes
-21.92M-107.75M-14.87M-8.08M-12.68M
Income Tax
-586.39K-9.46M-745.00K0.000.00
Net Income
-21.33M-106.25M-24.14M-8.08M-12.68M
EBITDA
-9.62M-14.41M-13.82M-7.69M-11.82M
 
Per Share Data
EPS Diluted Total Ops
-69.90-1.09K-917.81-307.38-482.25
Non GAAP EPS
-147.07N/AN/AN/AN/A
 
Statistics

All data in USD

Charts